Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
integrin antagonist
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Millennium_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
MLN341
|
| gptkbp:intendedUse |
treatment of inflammatory bowel disease
|
| gptkbp:mechanismOfAction |
blocks leukocyte adhesion
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
integrin α4β1
integrin α4β7 |
| gptkbp:bfsParent |
gptkb:168273-06-1
|
| gptkbp:bfsLayer |
8
|